Comprehensive, integrated, and phased whole-genome analysis of the primary ENCODE cell line K562
Open accessPublished version of a preprint
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
K562 is widely used in biomedical research. It is one of three tier-one cell lines of ENCODE and also most commonly used for large-scale CRISPR/Cas9 screens. Although its functional genomic and epigenomic characteristics have been extensively studied, its genome sequence and genomic structural features have never been comprehensively analyzed. Such information is essential for the correct interpretation and understanding of the vast troves of existing functional genomics and epigenomics data for K562. We performed and integrated deep-coverage whole-genome (short-insert), mate-pair, and linked-read sequencing as well as karyotyping and array CGH analysis to identify a wide spectrum of genome characteristics in K562: copy numbers (CN) of aneuploid chromosome segments at high-resolution, SNVs and indels (both corrected for CN in aneuploid regions), loss of heterozygosity, megabase-scale phased haplotypes often spanning entire chromosome arms, structural variants (SVs), including small and large-scale complex SVs and nonreference retrotransposon insertions. Many SVs were phased, assembled, and experimentally validated. We identified multiple allele-specific deletions and duplications within the tumor suppressor gene FHIT . Taking aneuploidy into account, we reanalyzed K562 RNA-seq and whole-genome bisulfite sequencing data for allele-specific expression and allele-specific DNA methylation. We also show examples of how deeper insights into regulatory complexity are gained by integrating genomic variant information and structural context with functional genomics and epigenomics data. Furthermore, using K562 haplotype information, we produced an allele-specific CRISPR targeting map. This comprehensive whole-genome analysis serves as a resource for future studies that utilize K562 as well as a framework for the analysis of other cancer genomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Van der Auwera, G. A., Carneiro, M. O., Hartl, C., Poplin, R., del Angel, G., Levy‐Moonshine, A., Jordan, T., Shakir, K., Roazen, D., Thibault, J., et al. (2013) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1110s43 · Cited by 6,687 · cited 2×
“…were then concatenated, and variant quality scores were recalibrated using training datasets (dbSNP 138, HapMap 3.3, Omni 2.5 genotypes, 1000 Genomes Phase 1) as recommended by the GATK Best Practices (Van der Auwera et al. 2013; DePristo et al. 2011) and filtered accordingly (tranche = 99.0).”
InfluentialLorenz, R., Bernhart, S. H., Höner zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., & Hofacker, I. L. (2011) · Algorithms for Molecular Biology · doi:10.1186/1748-7188-6-26 · Cited by 5,098
Accurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
An integrated map of structural variation in 2,504 human genomes
Sudmant, P. H., Rausch, T., Gardner, E. J., Handsaker, R. E., Abyzov, A., Huddleston, J., Zhang, Y., Ye, K., Jun, G., Hsi-Yang Fritz, M., et al. (2015) · Nature · doi:10.1038/nature15394 · Cited by 2,354
Self-citationCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
Research works printed but not linked: 46
- 10.1016/j.cmet.2016.08.017 · DOI · Paper page
- 10.1101/200170 · DOI
- 10.1093/nar/gkx712 · DOI
- 10.1111/imr.12129 · DOI
- 10.1038/nbt.3200 · DOI · Paper page
- 10.1007/s00439-016-1654-x · DOI
- 10.1038/nmeth.1363 · DOI · Paper page
- 10.1186/s13059-017-1158-6 · DOI · Paper page
- 10.1016/j.bbcan.2017.01.003 · DOI · Paper page
- 10.1016/j.leukres.2004.03.022 · DOI
- 10.1038/nature11247 · DOI · Paper page
- 10.1371/journal.pone.0044196 · DOI · Paper page
- 10.1186/s13073-014-0089-z · DOI · Paper page
- 10.1186/s13073-017-0447-8 · DOI · Paper page
- 10.1016/S0165-4608(99)00169-7 · DOI
- 10.1016/S0006-2952(03)00532-X · DOI
- 10.1038/nbt.3834 · DOI · Paper page
- 10.1186/s12885-015-2018-y · doi:10.1186/s12885-015-2018-y
- 10.1093/bioinformatics/bts697 · DOI · Paper page
- 10.1038/nbt.1740 · DOI · Paper page
- 10.1093/bioinformatics/btr167 · DOI · Paper page
- 10.1101/gr.092759.109 · DOI · Paper page
- 10.1038/nbt.1600 · DOI · Paper page
- 10.1038/nbt.2134 · DOI · Paper page
- 10.1186/gb-2014-15-6-r84 · DOI · Paper page
- 10.1093/bib/bbu047 · DOI
- 10.1126/science.aah7111 · DOI · Paper page
- 1975, Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome, Blood, 45, 321, 10.1182/blood.V45.3.321.321 · DOI · Paper page
- 10.1101/230946 · doi:10.1101/230946
- 10.1093/bioinformatics/btv204 · DOI · Paper page
- 10.1038/nbt.3567 · DOI · Paper page
- 10.1016/S0145-2126(00)00125-9 · DOI
- 10.1134/S1022795412050171 · doi:10.1134/s1022795412050171
- 10.1093/bib/bbs086 · DOI · Paper page
- 10.1016/j.ajhg.2007.12.010 · DOI · Paper page
- 10.1016/j.tig.2011.10.002 · DOI · Paper page
- 10.1073/pnas.80.23.7289 · DOI
- 10.1093/nar/gkv1160 · DOI · Paper page
- 10.1038/nrg3903 · DOI · Paper page
- 10.1038/nmeth.4366 · DOI · Paper page
- 10.1016/j.celrep.2015.12.052 · DOI · Paper page
- 10.1007/s00018-014-1722-0 · DOI
- 10.1101/gr.138925.112 · DOI
- 1995, Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562, Leukemia, 9, 858
- 10.1093/bioinformatics/btp394 · DOI · Paper page
- 10.1038/nbt.3432 · DOI · Paper page
Cited by
Structural variation in the sequencing era
Ho, S. S., Urban, A. E., & Mills, R. E. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0180-9 · Cited by 615
Self-citationA Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens
Gasperini, M., Hill, A. J., McFaline-Figueroa, J. L., Martin, B., Kim, S., Zhang, M. D., Jackson, D., Leith, A., Schreiber, J., Noble, W. S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.029 · Cited by 613
Meltome atlas—thermal proteome stability across the tree of life
Jarzab, A., Kurzawa, N., Hopf, T., Moerch, M., Zecha, J., Leijten, N., Bian, Y., Musiol, E., Maschberger, M., Stoehr, G., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0801-4 · Cited by 281
Rinzema, N. J., Sofiadis, K., Tjalsma, S. J. D., Verstegen, M. J. A. M., Oz, Y., Valdes-Quezada, C., Felder, A.-K., Filipovska, T., van der Elst, S., de Andrade dos Ramos, Z., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00787-7 · Cited by 166
“Because it is also present on three untargeted copies of chromosome 18 (K562 has four copies of our genomic segment 47 ), exclusive analysis of its characteristics on the targeted allele was not possible.”
HiNT: a computational method for detecting copy number variations and translocations from Hi-C data
Wang, S., Lee, S., Chu, C., Jain, D., Kerpedjiev, P., Nelson, G. M., Walsh, J. M., Alver, B. H., & Park, P. J. (2020) · Genome Biology · doi:10.1186/s13059-020-01986-5 · Cited by 99
Multi‐omics analysis reveals the functional transcription and potential translation of enhancers
Wu, Y., Yang, Y., Gu, H., Tao, B., Zhang, E., Wei, J., Wang, Z., Liu, A., Sun, R., Chen, M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33132 · Cited by 18
“We use K562 cell line from ENCODE project(36) which is abundant with multi-omics sequencing data.(37) To test whether RNA-seq detected eRNAs marks enhancer activity, we asked whether those RNA-generating enhancers are epigenetically active by using H3K27Ac,(38) H3K4me1(39) and H3K4me2(39) ChIP-seq which are widely acc…”
Method
Metadata
- Authors
- Zhou, B., Ho, S. S., Greer, S. U., Zhu, X., Bell, J. M., Arthur, J. G., Spies, N., Zhang, X., Byeon, S., Pattni, R., Ben-Efraim, N., Haney, M. S., Haraksingh, R. R., Song, G., Ji, H. P., Perrin, D., Wong, W. H., Abyzov, A., & Urban, A. E.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2019-02-08
- Volume
- 29
- Issue
- 3
- Pages
- 472-484
- ISSN
- 1088-9051 (ISSN-L)
- 1549-5469
- OpenAlex
- W2951759798
- Cited by
- 123
- References
- 23
- Type
- posted content
- Language
- en
- Open access
- bronze
- Funders
- National Institutes of Health
- NIH (T32-HL110952, T32-GM096982, U24CA220242)
- National Human Genome Research Institute
- NHGRI (P50-HG007735)
- Stanford Medicine Faculty Innovation Program
- NIH/NHGRI (R01-HG007834, P50-HG007735, R01-HG006137, P01-HG00205)
- National Science Foundation (DGE-114747)
- Intermountain Healthcare Research Award
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.